Market closed

Progyny/$PGNY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Progyny

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Ticker

$PGNY
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Providers & Services
Headquarters
New York, United States

Employees

565
Website
www.progyny.com

Progyny Metrics

BasicAdvanced
$1.7B
33.86
$0.60
1.44
-

$1.7B

1.44

$42.08

$13.39

1.8M

2.621

2.477

3.823

3.823

5.90%

12.05%

33.86

1.653

4.1

4.26

11.736

10.24%

17.45%

33.99%

-12.89%

What the Analysts think about Progyny

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Progyny stock.

Progyny Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Progyny Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Progyny News

AllArticlesVideos
The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying

The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying

Seeking Alpha·2 weeks ago
Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders

Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders

GlobeNewsWire·4 weeks ago
Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders

Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders

GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PGNY

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Progyny stock?

Progyny (PGNY) has a market cap of $1.7B as of January 15, 2025.

What is the P/E ratio for Progyny stock?

The price to earnings (P/E) ratio for Progyny (PGNY) stock is 33.86 as of January 15, 2025.

Does Progyny stock pay dividends?

No, Progyny (PGNY) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Progyny dividend payment date?

Progyny (PGNY) stock does not pay dividends to its shareholders.

What is the beta indicator for Progyny?

Progyny (PGNY) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.